PI
ARQT icon

PEAK6 Investments’s Arcutis Biotherapeutics ARQT Stock Holding History

PEAK6 Investments’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$558K Sell
60,000
-10,000
-14% -$98.7K ﹤0.01% 2249
2024
Q2 		$651K Buy
70,000
+40,000
+133% +$362K ﹤0.01% 2094
2024
Q1 		$297K Buy
30,000
+10,000
+50% +$74.6K ﹤0.01% 2803
2023
Q4 		$64.6K Buy
+20,000
New +$54.4K ﹤0.01% 3705

Other funds holding ARQT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's ARQT Position: Q3 2024 in Review

PEAK6 Investments reduced its Arcutis Biotherapeutics (ARQT) stake by 14% in Q3 2024, selling an estimated $98.7K and leaving 60,000 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

PEAK6 Investments first reported a position in ARQT in Q4 2023 and has held it in 4 quarters since. The position peaked at $651K in Q2 2024. 188 funds tracked by Wall St. Rank hold ARQT as of Q3 2024.

  • PEAK6 Investments held 60,000 shares of Arcutis Biotherapeutics worth $558K as of Q3 2024.
  • PEAK6 Investments sold 10,000 Arcutis Biotherapeutics shares in Q3 2024, an estimated $98.7K.
  • Arcutis Biotherapeutics made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2249 holding.
  • PEAK6 Investments first reported a position in Arcutis Biotherapeutics in Q4 2023 and has held it in 4 quarters since.
  • PEAK6 Investments's Arcutis Biotherapeutics position peaked at $651K in Q2 2024.
  • 188 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.